Browse Category

NYSE:RCUS News 8 January 2026

Arcus Biosciences (NYSE:RCUS) stock slides on Morgan Stanley downgrade as casdatifan 2026 timeline sharpens

Arcus Biosciences (NYSE:RCUS) stock slides on Morgan Stanley downgrade as casdatifan 2026 timeline sharpens

New York, January 8, 2026, 14:40 EST — Regular session Arcus Biosciences (RCUS) shares slid 9.3% to $21.05 in afternoon trading on Thursday, after earlier touching $22.70. The stock hit a session low of $21.02. Morgan Stanley cut its rating on Arcus to “equal weight” from “overweight” and trimmed its price target to $20 from $23, Investing.com reported, calling the…

Stock Market Today

  • Nifty 50, Sensex Forecast: Indian Stock Market Outlook for January 30
    January 29, 2026, 9:32 PM EST. The Indian stock market indices Sensex and Nifty 50 are expected to open lower on January 30 amidst mixed global cues. The Sensex closed at 82,566.37, up 221.69 points, and Nifty 50 ended at 25,418.90, gaining 76.15 points on January 29. Technical indicators point to a continued uptrend, with key support for Sensex at 82,200 and resistance near 82,800. Nifty 50 shows bullish signs with emphasis on maintaining above 25,300 support and a critical breakout above 25,500 for further gains towards 26,000. Derivatives data suggests a cautious approach near the 25,300-25,500 pivot range. Experts advise waiting for confirmed breaks before taking new positions.
Go toTop